Benzinga | Nov 9, 2021 11:10AM EST

Akoya Biosciences Q3 EPS $(0.31) Misses $(0.26) Estimate, Sales $13.50M Beat $12.98M Estimate

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.26) by 19.23 percent. This is a 87.3 percent increase over losses of $(2.44) per share from the same period last year. The company reported quarterly sales of $13.50 million which beat the analyst consensus estimate of $12.98 million by 4.01 percent. This is a 35.00 percent increase over sales of $10.00 million the same period last year.